CHRONIC RETENTION = RETENTION CHRONIQUEBOULTON D.1975; BRIT. J. ORAL SURG.; G.B.; DA. 1975; VOL. 13; NO 2; PP. 209-211Article

Women and Early MethodismBOULTON, D. J.Proceedings of the Wesley Historical Society London. 1981, Vol 43, Num 2, pp 13-17Article

THE CLASSIFICATION OF CHILDHOOD PSYCHOSES BY NUMERICAL TAXONOMY.PRIOR M; BOULTON D; GAJZAGO C et al.1975; J. CHILD PSYCHOL. PSYCHIATRY; G.B.; DA. 1975; VOL. 16; NO 4; PP. 321-330; BIBL. 1 P. 1/2Article

Estimation of drug concentrations in plasma from urinary excretion data : an illustration based on salbutamolBOULTON, D. W; FAWCETT, J. P.European journal of clinical pharmacology. 1998, Vol 53, Num 5, pp 373-374, issn 0031-6970Article

Determination of salbutamol enantiomers in human plasma and uring by chiral high-performance liquid chromatographyBOULTON, D. W; FAWCETT, J. P.Journal of chromatography. B, Biomedical applications. 1995, Vol 672, Num 1, pp 103-109Article

Extensive binding of the bioflavonoid quercetin to human plasma proteinsBOULTON, D. W; WALLE, U. K; WALLE, T et al.Journal of pharmacy and pharmacology. 1998, Vol 50, Num 2, pp 243-249, issn 0022-3573Article

Enantioselective disposition of salbutamol in man following oral and intravenous administrationBOULTON, D. W; FAWCETT, J. P.British journal of clinical pharmacology. 1996, Vol 41, Num 1, pp 35-40, issn 0306-5251Article

Fate of the flavonoid quercetin in human cell lines : Chemical instability and metabolismBOULTON, D. W; WALLE, U. K; WALLE, T et al.Journal of pharmacy and pharmacology. 1999, Vol 51, Num 3, pp 353-359, issn 0022-3573Article

Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluidsDAKERS, J. M; BOULTON, D. W; FAWCETT, J. P et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 704, Num 1-2, pp 215-220, issn 1387-2273Article

Microchemical structural determination of a peptoid covalently bound to a polymeric bead by Matrix-assisted laser desorption ionization time-of flight mass spectrometryZAMBIAS, R. A; BOULTON, D. A; GRIFFIN, P. R et al.Tetrahedron letters. 1994, Vol 35, Num 25, issn 0040-4039, 4254, 4283-4286 [5 p.]Article

Transplacental distribution of salbutamol enantiomers at Caesarian sectionBOULTON, D. W; FAWCETT, J. P; FIDDES, T. M et al.British journal of clinical pharmacology. 1997, Vol 44, Num 6, pp 587-590, issn 0306-5251Article

An induction parameter model for shock-induced hydrogen combustion simulationsCLIFFORD, L. J; MILNE, A. M; TURANYI, T et al.Combustion and flame. 1998, Vol 113, Num 1-2, pp 106-118, issn 0010-2180Article

Enantioselective disposition of albuterol in humansBOULTON, D. W; FAWCETT, J. P.Clinical reviews in allergy and immunology. 1996, Vol 14, Num 1, pp 115-138, issn 1080-0549Article

Lack of a pharmacokinetic drug―drug interaction between lithium and valproate when co-administered with aripiprazoleBOULTON, D. W; KOLLIA, G. D; MALLIKAARJUNT, S et al.Journal of clinical pharmacy and therapeutics (Print). 2012, Vol 37, Num 5, pp 565-570, issn 0269-4727, 6 p.Article

Stability of hydrocortisone oral suspensions prepared from tablets and powderFAWCETT, J. P; BOULTON, D. W; RUOYING JIANG et al.The Annals of pharmacotherapy. 1995, Vol 29, Num 10, pp 987-990, issn 1060-0280Article

Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy SubjectsKOMOROSKI, B; VACHHARAJANI, N; BOULTON, D et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 5, pp 520-526, issn 0009-9236, 7 p.Article

Human cytotoxic lymphocyte granzyme B : its purification from granules and the characterization of substrate and inhibitor specificityPOE, M; BLAKE, J. T; BOULTON, D. A et al.The Journal of biological chemistry (Print). 1991, Vol 266, Num 1, pp 98-103, issn 0021-9258, 6 p.Article

Disposition of morphine in tissues of the pregnant rat and foetus following single and continuous intraperitoneal administration to the motherDEVANE, C. L; SIMPKINS, J. W; BOULTON, D. W et al.Journal of pharmacy and pharmacology. 1999, Vol 51, Num 11, pp 1283-1287, issn 0022-3573Article

Human fibroblast stromelysin catalytic domain : expression, purification, and characterization of a C-terminally truncated formMARCY, A. I; EIBERGER, L. L; HARRISON, R et al.Biochemistry (Easton). 1991, Vol 30, Num 26, pp 6476-6483, issn 0006-2960Article

The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous and highly conserved peptidyl-prolyl Cis-Trans isomeraseSIEKIERKA, J. J; WIEDERRECHT, G; GREULICH, H et al.The Journal of biological chemistry (Print). 1990, Vol 265, Num 34, pp 21011-21015, issn 0021-9258, 5 p.Article

Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complexWIEDERRECHT, G; HUNG, S; KAREN CHAN, H et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 30, pp 21753-21760, issn 0021-9258Article

Syntheses and analgesic/antiinflammatory activities of novel 2-|5-aroyl pyrrolo|alkanoic acidsCHANG, M. N; BIFTU, T; BOULTON, D. A et al.European journal of medicinal chemistry. 1986, Vol 21, Num 5, pp 363-369, issn 0223-5234Article